Outcome analysis of pediatric hemophagocytic lymphohistiocytosis

被引:20
|
作者
Chen, Tsung-Yen [1 ,2 ]
Hsu, Mei-Hsin [1 ,3 ]
Kuo, Hsuan-Chang [1 ,4 ,5 ]
Sheen, Jiunn-Ming [6 ]
Cheng, Ming-Chou [1 ]
Lin, Ying-Jui [1 ,4 ]
机构
[1] Chang Gung Univ, Coll Med, Div Crit Care, Dept Pediat,Kaohsiung Chang Gung Mem Hosp, 123 Tapei Rd, Kaohsiung 333, Taiwan
[2] I Shou Univ, Dept Pediat, E Da Hosp, Kaohsiung, Taiwan
[3] Chang Gung Univ, Coll Med, Div Neurol, Dept Pediat,Kaohsiung Chang Gung Mem Hosp, Kaohsiung, Taiwan
[4] Chang Gung Univ, Coll Med, Div Cardiol, Dept Pediat,Kaohsiung Chang Gung Mem Hosp, Kaohsiung, Taiwan
[5] Meiho Univ, Dept Nursing, Neipu Township, Taiwan
[6] Chang Gung Univ, Coll Med, Div Hematol, Dept Pediat,Kaohsiung Chang Gung Mem Hosp, Kaohsiung, Taiwan
关键词
Pediatric hemophagocytic syndrome; Hemophagocytic lympho histiocytosis; Macrophage activation syndrome; Mortality; Intensive care unit;
D O I
10.1016/j.jfma.2020.03.025
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Purpose: Hemophagocytic lymphohistiocytosis (HLH) is a life-threatening disease associated with rapid clinical deterioration and the need for intensive care; therefore, it is essential to identify clinical parameters related to mortality and establish prognostic factors correlated with unfavorable outcome in high risk patients whose treatment may fail. Methods: Between January 2004 and December 2018, a total of 51 pediatric patients (less than 18 years old) who fulfilled the diagnostic criteria of HLH-2004 with documented results of bone marrow investigations at Kaohsiung Chang Gung Memorial Hospital were enrolled. The treatment protocol was based on hemophagocytic lymphohistiocytosis-94 (HLH-94) and HLH-2004. We retrospectively reviewed electronic medical records (EMR) including clinical features, length of intensive care unit (ICU) stay, serological tests, microscopic reports of bone marrow examination, and ultrasound examination reports at diagnosis to identify prognostic factors. The patients were divided into four groups based on etiology; these included infection associated hemophagocytic syndrome (IAHS), macrophage activation syndrome (MAS), malignancy associated hemophagocytic lymphohistiocytosis (MA-HLH), and idiopathic hemophagocytic lymphohistiocytosis (IHLH) to identify differences among the groups. Results: Out of 51 patients enrolled, 27 patients had IAHS, 12 MAS, 8 MA-HLH, and 4 IHLH. The median age at diagnosis was 7 years. The overall mortality rate was 15.7% (there was no mortality in the MA-HLH group); the mean length of ICU stay was 6 +/- 20.8 days. Longer activated partial thromboplastin time (aPTT) (p = 0.007), lower sodium concentration (p = 0.0007), and higher creatinine (p = 0.032) and aspartate aminotransferase (AST) (p = 0.017) were significantly related to mortality. Multivariate Cox regression analysis demonstrated that aPTT (p = 0.045, HR = 1.03, 95% CI = 1.0-1.1) was an independent risk factor for mortality. The receiver operating characteristic (ROC) curve showed that aPTT longer than 44.35 s was the cutoff value predicting mortality, with a sensitivity and specificity of 72% and 66.7%, respectively. Conclusion: MA-HLH had the lowest mortality rate, as most children died from the underlying malignant disease and not from HLH. Impaired liver and renal functions were related to mortality. Prolonged aPTT > 44.35 s is a strong predictive factor for mortality. Copyright (C) 2020, Formosan Medical Association. Published by Elsevier Taiwan LLC.
引用
收藏
页码:172 / 179
页数:8
相关论文
共 50 条
  • [1] Prognostic factors of early outcome in pediatric hemophagocytic lymphohistiocytosis: an analysis of 116 cases
    Bin, Qiong
    Gao, Jin-Hong
    Luo, Jian-Ming
    ANNALS OF HEMATOLOGY, 2016, 95 (09) : 1411 - 1418
  • [2] Prognostic factors of early outcome in pediatric hemophagocytic lymphohistiocytosis: an analysis of 116 cases
    Qiong Bin
    Jin-Hong Gao
    Jian-Ming Luo
    Annals of Hematology, 2016, 95 : 1411 - 1418
  • [3] Pediatric hemophagocytic lymphohistiocytosis
    Canna, Scott W.
    Marsh, Rebecca A.
    BLOOD, 2020, 135 (16) : 1332 - 1343
  • [4] Hemophagocytic Lymphohistiocytosis in a Pediatric Patient
    Waheed, Saad
    Gillani, Saima
    JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN, 2021, 31 (08): : 975 - 977
  • [5] Hemophagocytic lymphohistiocytosis: a case series analysis in a pediatric hospital
    Santos, Itallo Oliveira
    Neto, Ricardo Pasquini
    Bom, Ana Paula Kuczynski Pedro
    HEMATOLOGY TRANSFUSION AND CELL THERAPY, 2023, 45 (01) : 32 - 37
  • [6] Emapalumab for adult and pediatric patients with hemophagocytic lymphohistiocytosis
    Garonzi, Chiara
    Chinello, Matteo
    Cesaro, Simone
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2021, 14 (05) : 527 - 534
  • [7] Outcome of clonal hemophagocytic lymphohistiocytosis: Analysis of 32 cases
    Imashuku, S
    Hibi, S
    Tabata, Y
    Itoh, E
    Hashida, T
    Tsunamoto, K
    Ishimoto, K
    Kawano, F
    LEUKEMIA & LYMPHOMA, 2000, 37 (5-6) : 577 - 584
  • [8] Hemophagocytic Lymphohistiocytosis in Children
    Sasan, Mohammad Saeed
    Rakhshanizadeh, Forough
    Heidari, Elahe
    ARCHIVES OF PEDIATRIC INFECTIOUS DISEASES, 2019, 7 (03):
  • [9] HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS IN CRITICALLY ILL PATIENTS
    Knaak, Cornelia
    Schuster, Friederike S.
    Spies, Claudia
    Vorderwuelbecke, Gerald
    Nyvlt, Peter
    Schenk, Thomas
    Balzer, Felix
    La Rosee, Paul
    Janka, Gritta
    Brunkhorst, Frank M.
    Keh, Didier
    Lachmann, Gunnar
    SHOCK, 2020, 53 (06): : 701 - 709
  • [10] Diagnostic Challenges in Pediatric Hemophagocytic Lymphohistiocytosis
    Si, Stephanie J.
    Tasian, Sarah K.
    Bassiri, Hamid
    Fisher, Brian T.
    Atalla, Jasmyn
    Patel, Reema
    Romberg, Neil
    Lambert, Michele P.
    Paessler, Michele
    Behrens, Edward J.
    Teachey, David T.
    Sullivan, Kathleen E.
    JOURNAL OF CLINICAL IMMUNOLOGY, 2021, 41 (06) : 1213 - 1218